HCAT - Health Catalyst - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HCAT is currently covered by 14 analysts with an average price target of $12.42. This is a potential upside of $4.29 (52.77%) from yesterday's end of day stock price of $8.13.

Health Catalyst's activity chart (see below) currently has 129 price targets and 131 ratings on display. The stock rating distribution of HCAT is 33.33% HOLD and 66.67% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.59% with an average time for these price targets to be met of 103.06 days.

Highest price target for HCAT is $14, Lowest price target is $9, average price target is $12.42.

Most recent stock forecast was given by DANIEL GROSSLIGHT from CITI on 13-Nov-2024. First documented stock forecast 19-Aug-2019.

Currently out of the existing stock ratings of HCAT, 15 are a HOLD (33.33%), 30 are a BUY (66.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$10.5

$2.37 (29.15%)

$12

11 days ago
(13-Nov-2024)

3/9 (33.33%)

$1.69 (19.18%)

269

Hold

$9

$0.87 (10.70%)

$8

17 days ago
(07-Nov-2024)

7/13 (53.85%)

$0.43 (5.02%)

45

Buy

$10

$1.87 (23.00%)

$8

1 months 16 days ago
(08-Oct-2024)

4/8 (50%)

$2.17 (27.71%)

69

Buy

$11

$2.87 (35.30%)

$14

2 months 29 days ago
(26-Aug-2024)

2/11 (18.18%)

$3.84 (53.63%)

1

Buy

$11

$2.87 (35.30%)

$11

6 months 3 days ago
(21-May-2024)

4/11 (36.36%)

$4.23 (62.48%)

96

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HCAT (Health Catalyst) average time for price targets to be met?

On average it took 103.06 days on average for the stock forecasts to be realized with a an average price target met ratio 37.59

Which analyst has the current highest performing score on HCAT (Health Catalyst) with a proven track record?

STEVEN HALPER

Which analyst has the most public recommendations on HCAT (Health Catalyst)?

Steven Halper has 9 price targets and 6 ratings on HCAT

Which analyst is the currently most bullish on HCAT (Health Catalyst)?

Sandy Draper with highest potential upside - $50.22

Which analyst is the currently most reserved on HCAT (Health Catalyst)?

John Ransom with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?